Uptake of biosimilars for TNF-α inhibitors adalimumab and etanercept following the best-value biological medicine initiative in Ireland
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Clinical Pharmacy"
DOI: 10.1007/s11096-021-01243-0
Abstract: Background There is over 10 years of clinical experience and evidence to show that biosimilar medicines can be used as safely and effectively in approved therapeutic indications as their originator biological medicines. In Ireland, biosimilar… read more here.
Keywords: medicine; adalimumab etanercept; value biological; best value ... See more keywords